MarketsStocksLYKALABS
LY

Lyka Labs Ltd

NSE: LYKALABSBSE: 500259Healthcare
Download Research Report7-page PDF
63.60
+0.05%
NSE · auto-updates while market open
Prev Close
₹116.32
Day High
₹67.02
Day Low
₹61.38
Mkt Cap
₹226 Cr
P / E
26.2
P / B
2.5
ROE
-10.7%
52W High
₹125.50
52W Low
₹44.10
Key Metrics
Market Cap
₹226 Cr
P / E
26.22
P / B
2.46
EV / EBITDA
55.06
ROCE
-6.1%
ROE
-10.7%
Debt / Equity
0.52
Book Value
₹25.89
EPS
-
Div Yield
0.0%
Face Value
₹10
Promoter Holding
58.2%
Revenue · ₹ Cr
61
FY20
86
FY21
194
FY22
93
FY23
111
FY24
138
FY25
128
FY26
Net Profit · ₹ Cr
39
8
-63
-12
-13
-3
-10
FY20FY21FY22FY23FY24FY25FY26
EPS · ₹ per share
₹13.6
₹2.2
₹-1.8
₹-27.3
₹-4.1
₹-4.6
₹-0.8
FY19FY20FY21FY22FY23FY24FY25
P / E Ratio · price ÷ TTM EPS
034969710462360-11Jun 21Feb 23Oct 24Jun 26
P/E 749.2×Median 18.3×TTM EPS
Q1 2026 snapshot
Sales
₹29 Cr
Operating profit
-
OPM
-
Net profit
₹-8 Cr
EPS
₹-2.13
Scorecard · 7 axes
Quality
Bad
28/100
Valuation
Avg
26.2×
Growth
Bad
-22.8%
Profitability
Bad
-8.4%
Performance
Bad
-45.8%
Entry Point
Strong
51%
Red Flags
Strong
0 flags
Shareholding Pattern
58.2%Promoter
Promoter58.2%
FII0.3%
DII0.7%
Public40.9%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue33.79833.4333.6637.7531.8928.64
Net Profit2.7042.030.996-3.214-0.151-8.066
NPM %8.0%6.1%3.0%-8.5%-0.5%-28.2%
AlertPre-trade